184 related articles for article (PubMed ID: 14983012)
1. The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis.
Saucier C; Khoury H; Lai KM; Peschard P; Dankort D; Naujokas MA; Holash J; Yancopoulos GD; Muller WJ; Pawson T; Park M
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2345-50. PubMed ID: 14983012
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO
J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688
[TBL] [Abstract][Full Text] [Related]
3. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
[TBL] [Abstract][Full Text] [Related]
4. The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.
Warner AJ; Lopez-Dee J; Knight EL; Feramisco JR; Prigent SA
Biochem J; 2000 Apr; 347(Pt 2):501-9. PubMed ID: 10749680
[TBL] [Abstract][Full Text] [Related]
5. The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner.
Im YK; La Selva R; Gandin V; Ha JR; Sabourin V; Sonenberg N; Pawson T; Topisirovic I; Ursini-Siegel J
Oncogene; 2015 Mar; 34(13):1729-35. PubMed ID: 24837366
[TBL] [Abstract][Full Text] [Related]
6. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
[TBL] [Abstract][Full Text] [Related]
7. Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions.
Pomerleau V; Landry M; Bernier J; Vachon PH; Saucier C
BMC Cancer; 2014 Apr; 14():240. PubMed ID: 24708867
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.
Yu L; Saile K; Swartz CD; He H; Zheng X; Kissling GE; Di X; Lucas S; Robboy SJ; Dixon D
Mol Med; 2008; 14(5-6):264-75. PubMed ID: 18231572
[TBL] [Abstract][Full Text] [Related]
10. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase.
Ricci A; Lanfrancone L; Chiari R; Belardo G; Pertica C; Natali PG; Pelicci PG; Segatto O
Oncogene; 1995 Oct; 11(8):1519-29. PubMed ID: 7478576
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1.
Neumann C; Zehentmaier G; Danhauser-Riedl S; Emmerich B; Hallek M
Eur J Immunol; 1996 Feb; 26(2):379-84. PubMed ID: 8617307
[TBL] [Abstract][Full Text] [Related]
12. Protein-tyrosine phosphatase epsilon regulates Shc signaling in a kinase-specific manner: increasing coherence in tyrosine phosphatase signaling.
Kraut-Cohen J; Muller WJ; Elson A
J Biol Chem; 2008 Feb; 283(8):4612-21. PubMed ID: 18093973
[TBL] [Abstract][Full Text] [Related]
13. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor.
Chen Y; Grall D; Salcini AE; Pelicci PG; Pouysségur J; Van Obberghen-Schilling E
EMBO J; 1996 Mar; 15(5):1037-44. PubMed ID: 8605873
[TBL] [Abstract][Full Text] [Related]
14. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth.
Trusolino L; Bertotti A; Comoglio PM
Cell; 2001 Nov; 107(5):643-54. PubMed ID: 11733063
[TBL] [Abstract][Full Text] [Related]
15. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
Smit L; van der Horst G; Borst J
Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
[TBL] [Abstract][Full Text] [Related]
17. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression.
Stevenson LE; Frackelton AR
Breast Cancer Res Treat; 1998 May; 49(2):119-28. PubMed ID: 9696394
[TBL] [Abstract][Full Text] [Related]
18. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
[TBL] [Abstract][Full Text] [Related]
19. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
Liu SK; McGlade CJ
Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
[TBL] [Abstract][Full Text] [Related]
20. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG
Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
